investorscraft@gmail.com

Intrinsic ValuePerrot Duval Holding S.A. (PEDU.SW)

Previous CloseCHF50.00
Intrinsic Value
Upside potential
Previous Close
CHF50.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2025 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Perrot Duval Holding S.A. operates in the industrial machinery sector, specializing in automation technologies for process automation. The company develops and sells original components and solutions tailored for industries such as chemicals, pharmaceuticals, food, and cosmetics. Its core offerings include automated dispensing and safety systems, which streamline manufacturing processes for paints, inks, dyes, and other specialty products. Perrot Duval serves a global clientele, positioning itself as a niche provider of precision automation solutions. The company’s market position is reinforced by its focus on high-value, customized systems that enhance efficiency in complex production environments. While it operates in a competitive industrial automation space, its specialization in dispensing technologies for chemical and pharmaceutical applications provides a defensible niche. However, its small scale relative to multinational competitors may limit its ability to compete on price or broad technological integration.

Revenue Profitability And Efficiency

In FY 2024, Perrot Duval reported revenue of CHF 18.2 million but recorded a net loss of CHF 286,000, reflecting margin pressures or operational inefficiencies. The diluted EPS of -2.13 CHF underscores these challenges. Operating cash flow was positive at CHF 630,000, though capital expenditures of CHF 791,000 suggest ongoing investments, possibly in R&D or capacity upgrades.

Earnings Power And Capital Efficiency

The company’s negative net income indicates weak earnings power, though its modest debt (CHF 426,000) and cash reserves (CHF 3.2 million) provide some financial flexibility. The positive operating cash flow suggests core operations are generating liquidity, but profitability remains a concern given the net loss.

Balance Sheet And Financial Health

Perrot Duval maintains a conservative balance sheet with CHF 3.2 million in cash and limited total debt (CHF 426,000). This low leverage supports financial stability, though the net loss and negative EPS highlight operational challenges. The company’s ability to sustain dividends (CHF 1 per share) despite losses may indicate confidence in future cash flows or a commitment to shareholder returns.

Growth Trends And Dividend Policy

Revenue trends are unclear without prior-year comparisons, but the net loss suggests stagnant or declining profitability. The dividend payout of CHF 1 per share is notable given the negative earnings, potentially signaling a prioritization of shareholder returns over reinvestment. Future growth may hinge on expanding its automation solutions in niche chemical and pharmaceutical markets.

Valuation And Market Expectations

With a market cap of CHF 7.8 million and a beta of 0.14, the stock is thinly traded and exhibits low volatility. The negative earnings and modest revenue base likely limit investor enthusiasm, though the dividend yield could attract income-focused shareholders. The valuation reflects skepticism about near-term turnaround prospects.

Strategic Advantages And Outlook

Perrot Duval’s specialization in dispensing systems for chemicals and pharmaceuticals provides a competitive edge in niche markets. However, its small scale and recent losses pose risks. The outlook depends on its ability to improve margins, expand its customer base, or innovate in high-value automation segments. A focus on operational efficiency and targeted R&D could help stabilize profitability.

Sources

Company description, financial data from public filings (likely Swiss Exchange disclosures), and market data from financial platforms.

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2026202720282029203020312032203320342035203620372038203920402041204220432044204520462047204820492050

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount